A Multicentre, Randomised, Double-blind, Placebo-parallel Controlled Phase Ⅲ Clinical Trial Evaluating the Efficacy and Safety of BXOS110 Injection in the Treatment of Acute Ischaemic Stroke Within 3 Hours of Onset.

​ Conditions: AIS Interventions: Drug: BXOS110; Drug: placebo Sponsors: Biocells (Beijing) Biotech Co.,Ltd Recruiting Conditions: AIS Interventions: Drug: BXOS110; Drug: placebo Sponsors: Biocells (Beijing) Biotech Co.,Ltd...